Editor Profile

editor profile image is not found.

Usama Abdel Azim Abdel Salam Sharaf El Din

Professor

Present

Cairo University

Cairo

Egypt

editor profile QR Code is not found.

Name: Usama Abdel Azim Abdel Salam Sharaf El Din

Date of Birth: 10th of August,1954

Professor of Internal Medicine & Nephrology in School of Medicine, Cairo University, Cairo, Egypt starting by September 1998, till August 2014.

Emeritus Professor of Internal Medicine & Nephrology in School of Medicine, Cairo University Since August 2014.

Ex President of the Nephrology and Dialysis Unit Kasr El Aini Hospitals Board member, Internal Medicine Promotion Committee, Supreme Council of Universities, MOHE, Egypt.

President of the Vascular Calcification group.

Peer reviewer in 10 international indexed medical journals in the field of Internal Medicine, Nephrology, Urology and Diabetes.

  • Clinical Nephropathy
  • Diabetic Complication
  • Preventive Nephrology
  • Kidney Transplantation
  • A Fayed, AA Hammad, DO Abdulazim, H Hammad, M Amin, S Elhadidy,, U A Sharaf El Din Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study. Renal Failure 45 (1), 2194434.
  • D O Abdulazim, S A Husein, M E Saraya, M M ElSharkawy, A Fayed, U A Sharaf El Din, N N Eesa Fibroblast growth factor-23 in systemic lupus erythematosus patients: Is there a correlation with interleukin-6 and left ventricular mass? The Egyptian Rheumatologist Volume 44, Issue 3, June 2022, Pages 233-237 doi/10.1016/j.ejr. 2021.12.009.
  • Usama AA Sharaf El Din, M Salem, D. AbdulAzim Sodium- glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease. Nefrologia, 2021 Aug 24;S0211-6995(21)00143-0.doi: 10.1016/j.nefro.2021.03.014. Online ahead of print.
  • A Fayed, DO Abdulazim, M Amin, S Elhadidy, HH Samir, MM Salem,et al., Serum Sclerostin in acute kidney injury patients. Nefrología (English Edition) 42 (1), 50-55. DOI: 10.1016/j.nefro.2021.01.010.
  • AA Mohammed, M A Marie, D O Abdulazim, M Hassan, O Shaker, G Ayeldeen, M M Salem, U A Sharaf El Din Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study. Nephron. 2021;145(2):133-136. doi: 10.1159/000512340.
  • M M Salem, D O Abdulazim, A Abdo, M Hassan, E Rashad, U A Sharaf El Din Dapagliflozin in a non-diabetic pregnant ckd lady an evidence for the safety of sglt2 inhibitors during pregnancy. J Kidney Treat Diagn 2020;3(3):0-1.
  • UA Sharaf ElDin, DO Abdulazim, A Abdo, M Hassan, E Rashad Acute antibody mediated rejection associated with acute herpetic gingiva-stomatitis in kidney transplant patient: A case report. International Journal of Clinical Case Reports and Reviews. 2020;4:4.
  • A Fayed, A Soliman, H El Mahdy, W Hamza, D O Abdulazim, M M Salem, U A Sharaf El Din Impact of Hepatitis Virus Infection on Arterial Calcification Among Incident Hemodialysis Patients. Nefrologia 40 (3), 336-344. DOI: 10.1016/j.nefro. 2019.09.005.
  • UA Sharaf El Din, A Fayed, M M El Nokeety, D O Abdulazim, M M Salem Vitamin-D deficiency is encountered in almost all egyptian stage 3-5 chronic kidney disease patients in spite of the sunny weather. Saudi J Kidney Dis Transpl . 2019. Nov-Dec;30(6):1389-1397.doi: 10.4103/1319-2442.275483.
  • M M Salem, UA Sharaf El Din, D O Abdulazim Should We Change the Therapeutic Algorithm of Type 2 Diabetes Based on Accumulating Evidence? Global Journal of Medical Research: 2019 Volume 19 Issue 5 Version 1.0 Y.
  • A Fayed, M M Elnokeety, K Attia, U A Sharaf El Din Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):819-824. doi: 10.4103/1319-2442.265457.
  • UA Sharaf El Din, MM Salem, DO Abdulazim Time to Prevent the Development of Diabetic Nephropathy in Both Type 1 and Type 2 Diabetic Patients. J Clin Nephrol Kidney Dis. 2019; 4 (1) 1023.
  • A Fayed, M M El Nokeety, A A Heikal, K M Sadek, H Hammad, D O Abdulazim, M M Salem, U A Sharaf El Din, Vascular Calcification Group (VCG) Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients. Ren Fail 2019 Nov;41(1):540-546. doi: 10.1080/0886022X.2018.1563552.
  • A Fayed, A Soliman, H El Mahdy, W Hamza, D O Abdulazim, M M Salem, U A Sharaf El Din Intraoperative Arterial Biopsy in Incident Hemodialysis Patients: Differences Observed. Nephron. 2019;143(1):54-61. doi: 10.1159/000500486. Epub 2019 Jun 6.
  • Abdulazim DO, Fayed A, El-Nokeety MM, et al. Negative Association between Serum 25 Hydroxy Vitamin D and Serum Uric Acid among Stage 3-5 Chronic Kidney Disease Patients Ann Med Health Sci Res. 2018;8:87-90.
  • Abdulazim DO, Salem MM, Hassan M, Abdo A, Rashad E, Sharaf El Din UAA.Vitamin D deficiency: an unrecognized cause of flank pain.J Bone Miner Metab. 2018 Sep;36(5):605-608. doi: 10.1007/s00774-017-0874-z.
  • Fayed A, El Nokeety MM, Heikal AA, et al., Serum 25-hydroxyvitamin D level is negatively associated with serum phosphorus level among stage 3a-5 chronic kidney disease patients. Nefrologia. 2018 May 26. pii: S0211-6995(18)30066-3. doi: 10.1016/j.nefro.2018.02.011.
  • Fayed A, El Nokeety MM, Heikal AA, et al., Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.Ren Fail. 2018 Nov;40(1):226-230. doi: 10.1080/0886022X.2018.1455594.
  • A Fayed, M M El Nokeety, AA Heikal, H Hammad, D O Abdulazim, M M Salem, M M Naguib Is 25-Hydroxy Vitamin D a Real Index of Vitamin D Status in Pre-Dialysis Chronic Kidney Disease Patients?- Int J Nephrol Ther; 2018, 4,1.
  • M Sayed, M EL Sharkawy, H Okasha, H Hussien, R F Salam, W Al Nabaoy, M S Makboul, UA Sharaf El Din, M M Salem Diagnostic Value of High Resolution Neck ultrasongraghy, Fine Needle Aspiration Cytology and BRAFV600E Mutation in Diagnosis of Malignant Thyroid Nodules. J Endocrinol Thyroid Res 2(1): JETR. MS. ID.555580 (2017).
  • Sharaf El Din UAA, Salem MM, Abdulazim DO. Diabetic nephropathy: Time to withhold development and progression - A review. J Adv Res. 2017 Jul;8(4):363-373. doi: 10.1016/j.jare.2017.04.004.
  • Sharaf El Din UAA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res. 2017 Sep;8(5):537-548. doi: 10.1016/j.jare.2016.11.004.
  • Sharaf El Din UA, Salem MM, Abdulazim DO. Recent Advances in Management of Diabetic Nephropathy. J Clin Exp Nephrol 2:35, May 29, 2017. doi: 10.21767/2472-5056.100035.
  • Sharaf El Din UA, Salem MM, Abdulazim DO. Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review. J Adv Res. 2017 May;8(3):271-278. doi: 10.1016/j.jare.2017.02.003.
  • Sharaf El Din UA, Salem MM, Abdulazim DO. FGF23 and inflammation. World J Nephrol. 2017 Jan 6;6(1):57-58. doi: 10.5527/wjn.v6.i1.57.
  • U A Sharaf El Din, M M Elnokeety, N A Osman, A M Shaker, A M Fayed, M T Ali, M M Elsebaie Prevalence and severity of abdominal aortic calcification in incident nondiabetic hemodialysis patients. International Journal of Current Multidisciplinary Studies 2017, Vol. 3, Issue,10, pp.811-814.
  • Sharaf El Din UA, Salem MM, Abdulazim DO. Stop chronic kidney disease progression: Time is approaching. World J Nephrol. 2016 May 6;5(3):258-73. doi: 10.5527/wjn.v5.i3.258.
  • NasrAllah MM, Nassef A, Elshaboni TH, et al. Comparing different calcification scores to detect outcomes in chronic kidney disease patients with vascular calcification. Int J Cardiol. 2016 Oct 1;220:884-9. doi: 10.1016/j.ijcard.2016.06.064.
  • Germain DP, Hughes DA, Nicholls K, et al. Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat. N Engl J Med. 2016 Aug 11;375(6):545- 55. doi: 10.1056/NEJMoa1510198.
  • Sharaf El Din UA, Salem MM, Abdulazim DO. Vascular calcification: When should we interfere in chronic kidney disease patients and how? World J Nephrol. 2016 Sep 6;5(5):398-417. doi: 10.5527/wjn.v5.i5.398.
  • Sharaf Din UA, Salem MM, Abdulazim DO. Arterial Calcification in Chronic Kidney Disease: Whom? When? and How to Handle?. J UrolNephrol. 2016;3(1): 10.
  • M Elansary, H E El Haddad, UA Sharaf Eldin, A Hamdy, M M Sherif Seroprevalence and real-time PCR study of Epstein—Barr virus and the value of screening in pretransplant patients The Egyptian Journal of Internal Medicine 2016, 28 (1), 9-15.
  • Sharaf El Din UAA*, Zayed BED, Al-Shihaby AR, Salem MA and Salem MM Low Dose of Sevelamer is Enough to Prevent Coronary Artery Calcification Progression in Prevalent Hemodialysis Patients. Open Access Journal of Urology & Nephrology August 26, 2016 DOI: 10.23880/OAJUN-16000107.
  • El Haddad HE, Marie MA, Samy TM, et al. Tumor necrosis factor gene expression in regular hemodialysis patients.Saudi J Kidney Dis Transpl. 2015 May-Jun;26(3):460-7. doi: 10.4103/1319-2442.157309.
  • Nasrallah MM, El-Shehaby AR, Osman NA, et al. The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers.Nephron Extra. 2013 Nov 6;3(1):106-112.
  • Nasrallah MM, El-Shehaby AR, Osman NA, et al. ENDOGENOUS SOLUBLE RECEPTOR OF ADVANCED GLYCATION END-PRODUCTS (ESRAGE) IS NEGATIVELY ASSOCIATED WITH VASCULAR CALCIFICATION IN NON-DIABETIC HEMODIALYSISPATIENTS. Int Urol Nephrol. 2012 Aug;44(4):1193-9. doi: 10.1007/s11255-011-0007-x.
  • Nasrallah MM, El-Shehaby AR, Salem MM, et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.Nephrol Dial Transplant. 2010 Aug;25(8):2679-85. doi: 10.1093/ndt/gfq089.
  • A R Soliman, U A Sharafeldin, A Soliman Increased Death From Cardiovascular And Infectious Causes In Far Living Renal Transplant (Rtx) Patients. RANSPLANT INTERNATIONAL 2009; 22: 227-228.
  • Sharaf El Din U Five-year experience in kidney transplantation of hcv positive recipients in egypt African J Nephrology 7 41-51, 2003.
  • Sharaf El Din U, Mansour M, El Sersawy G, El Fiki A F, El Shimi Nihad, Sayed Mohamad T-cell function in long term haemodialysis patients: impact of secondary hyperparathyroidism, oral one alpha calcidol and dialysis duration. 2003, 289-295.
  • UA SharafElDin, AR Soliman, M Mansour, H Abdelrahman, H Darwich, H Gaafer, MR Francis, EG El Ghonaimy DISCREPANCY IN URINARY EICOSANOIDS EXCRETION BETWEEN 2 DISTINCT FORMS OF PROLIFERATIVE GN JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1995; 6(3), 432.
    No content available to display!!!